GeneBioTech Co. Ltd (086060) — Free Cash Flow Generation Index
GeneBioTech Co. Ltd (086060) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of ₩2.06 Billion represents 1% of operating cash flow (₩2.15 Billion). Explore GeneBioTech Co. Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneBioTech Co. Ltd Free Cash Flow Generation Index (2009–2025)
Historical FCF Generation Index trend for GeneBioTech Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see GeneBioTech Co. Ltd cash conversion from operations.
Annual Free Cash Flow Generation for GeneBioTech Co. Ltd (2009–2025)
Year-by-year Free Cash Flow Generation Index for GeneBioTech Co. Ltd. Check total reinvestment intensity of GeneBioTech Co. Ltd to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | ₩3.85 Billion | ₩7.61 Billion | ₩3.76 Billion | ▼ -43.5% |
| 2023 | 0.90x | ₩6.60 Billion | ₩7.37 Billion | ₩766.93 Million | ▲ +217.8% |
| 2020 | -0.76x | ₩-1.90 Billion | ₩2.49 Billion | ₩4.39 Billion | ▼ -169.5% |
| 2018 | 1.09x | ₩6.51 Billion | ₩5.96 Billion | ₩558.47 Million | ▼ -44.7% |
| 2017 | 1.98x | ₩2.24 Billion | ₩1.13 Billion | ₩1.11 Billion | ▲ +59.0% |
| 2016 | 1.24x | ₩6.61 Billion | ₩5.31 Billion | ₩1.30 Billion | ▼ -8.3% |
| 2015 | 1.36x | ₩3.53 Billion | ₩2.61 Billion | ₩927.06 Million | ▲ +9.6% |
| 2014 | 1.24x | ₩2.67 Billion | ₩2.15 Billion | ₩510.55 Million | ▼ -0.6% |
| 2013 | 1.24x | ₩2.96 Billion | ₩2.38 Billion | ₩582.01 Million | ▼ -37.6% |
| 2011 | 1.99x | ₩5.04 Billion | ₩2.53 Billion | ₩2.51 Billion | ▲ +25.0% |
| 2010 | 1.60x | ₩1.86 Billion | ₩1.17 Billion | ₩693.45 Million | ▲ +46.9% |
| 2009 | 1.09x | ₩2.91 Billion | ₩2.68 Billion | ₩229.99 Million | — |